Ritter Pharmaceuticals implements 1-for-10 reverse stock split
Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion
Global M&A by the Numbers: Q2 2022
Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms
Infographic 2022 Top Tech Trends Shaping Corporations
Los Angeles-based Ritter Pharmaceuticals Inc. implemented a 1-for-10 reverse split of its common stock, effective March 23.
The split will reduce Ritter's issued and outstanding common shares to 4,940,652 from 49,406,521.
Corporate Stock Transfer Inc. is acting as exchange agent for the split.